Ann: MVP acquires Avita Medicals Australian Respiratory Business, page-6

EXTRACT from Avita 2015 Stat Accounts
"The Company manufactures and sells a range of spacers for the paediatric, adolescent and adult market and is the leading provider of spacers in Australia. Products include the Funhaler® incentive asthma spacer, designed for the paediatric market, and Breath-A- Tech addressing the adolescent and adult markets."
Funhaler - http://www.ncbi.nlm.nih.gov/pubmed/15612962 Retails for around $35 a unit
Breath-A-Tech - retails for around $15

I am unable to identify the revenue generated by the sale of respiratory products by Avita and invite other forum members to help investigate the immediate revenue impact of the sale of these spacers. I expect that a lead product in the Australian market should achieve significant market penetration in other markets MDI operate in. Hope management can provide more information soon.

Happy New Year!